Sarah C Hurt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sarah C Hurt

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Inherited Metabolic Disease|June 30, 2021

Mucopolysaccharidoses type I gene therapySarah C Hurt, Patricia I Dickson, David T Curiel

Molecular Genetics and Metabolism Reports|January 4, 2024

Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type ISarah C Hurt, Moin U Vera, Steven Q Le, et al.

Molecular Therapy. Methods & Clinical Development|March 24, 2025

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I miceSarah C Hurt, Steven Q Le, Shih-Hsin Kan, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Inherited Metabolic Disease|June 30, 2021

Mucopolysaccharidoses type I gene therapySarah C Hurt, Patricia I Dickson, David T Curiel

Molecular Genetics and Metabolism Reports|January 4, 2024

Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type ISarah C Hurt, Moin U Vera, Steven Q Le, et al.

Molecular Therapy. Methods & Clinical Development|March 24, 2025

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I miceSarah C Hurt, Steven Q Le, Shih-Hsin Kan, et al.

Pageof 1